In contrast to pregnancy-associated thrombotic thrombocytopenic purpura, the pathogenesis
and presentation of pregnancy-associated atypical hemolytic uremic syndrome (P-aHUS) …

Pregnancy-associated atypical hemolytic uremic syndrome (aHUS) refers to the thrombotic
microangiopathy resulting from uncontrolled complement activation during pregnancy or the …

Background Atypical hemolytic uremic syndrome (aHUS) is a rare disease in which
uncontrolled terminal complement activation leads to systemic thrombotic microangiopathy …

Atypical HUS (aHUS) is a disorder most commonly caused by inherited defects of the
alternative pathway of complement, or the proteins that regulate this pathway, and life …

Background Pregnancy is associated with various forms of thrombotic microangiopathy,
including hemolytic uremic syndrome. A previous small French study suggested that …

Studies of complement genetics have changed the landscape of thrombotic
microangiopathies (TMAs), particularly atypical haemolytic uraemic syndrome (aHUS) …

OBJECTIVE: To evaluate disease presentation, diagnosis, treatment, and clinical outcomes
in pregnancy-associated atypical hemolytic uremic syndrome (aHUS). DATA SOURCES: We …

Complement dysregulation leads to atypical hemolytic uremic syndrome (aHUS), while
ADAMTS13 deficiency causes thrombotic thrombocytopenic purpura. We investigated …

Until recently, atypical hemolytic uremic syndrome (aHUS), conventionally defined in the
pediatric literature as a syndrome of the triad of renal failure, microangiopathic hemolytic …

Atypical hemolytic uremic syndrome (aHUS) is a rare, genetic, progressive, life-threatening
form of thrombotic microangiopathy (TMA) predominantly caused by dysregulation of the …